PURPOSE: Triple therapy (long-acting muscarinic antagonist/long-acting
- Vogelmeier, C. F.
- Beeh, K. M.
- Schultze, M.
- Kossack, N.
- Richter, L. M.
- Claussen, J.
- Compton, C.
- Noorduyn, S. G.
- Ismaila, A. S.
- Requena, G.
Keywords
- Humans
- *Pulmonary Disease, Chronic Obstructive/drug therapy/diagnosis/physiopathology
- Male
- Female
- Germany
- *Medication Adherence
- Aged
- Retrospective Studies
- Middle Aged
- *Adrenergic beta-2 Receptor Agonists/administration & dosage
- Administration, Inhalation
- *Muscarinic Antagonists/administration & dosage
- *Bronchodilator Agents/administration & dosage
- *Drug Combinations
- Treatment Outcome
- Quinuclidines/administration & dosage
- Time Factors
- Databases, Factual
- Chlorobenzenes/administration & dosage/therapeutic use
- Administrative Claims, Healthcare
- Drug Therapy, Combination
- Benzyl Alcohols/administration & dosage/therapeutic use
- Nebulizers and Vaporizers
- Glycopyrrolate/administration & dosage
- Lung/drug effects/physiopathology
- comparative
- multiple- or single-inhaler triple therapy
- new-user
- proportion of days covered
- real-world analysis
- treatment discontinuation
